Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway (Q39987613)

16 September 2017

Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway (English)

1 reference

16 September 2017

0 references

1 reference

2

1 reference

16 September 2017

6

Jean-Charles Soria

0 references

Salem Chouaib

8

object named as

Salem Chouaib

1 reference

16 September 2017

9

Fathia Mami-Chouaib

1 reference

16 September 2017

Béatrice Le Maux Chansac

1

1 reference

16 September 2017

Catherine Richon

3

1 reference

16 September 2017

Isabelle Vergnon

4

1 reference

16 September 2017

Marek Kubin

5

1 reference

16 September 2017

Alessandro Moretta

7

1 reference

16 September 2017

25 April 2008

1 reference

16 September 2017

International Immunology

1 reference

16 September 2017

20

1 reference

16 September 2017

7

1 reference

16 September 2017

801-810

1 reference

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

16 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Shear stress-induced shedding of soluble intercellular adhesion molecule-1 from saphenous vein endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Proteolytic release of soluble UL16-binding protein 2 from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

A renaissance for the tumor immunosurveillance hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Cytokines as a link between innate and adaptive antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXN038

21 January 2018

Identifiers

DOI

10.1093/INTIMM/DXN038

1 reference

16 September 2017

1 reference